Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ: LNTH )

100.85 -3.77 (-3.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,256,560
Open 105.13
Bid (Size) 75.00 (1)
Ask (Size) 101.80 (1)
Prev. Close 104.62
Today's Range 97.77 - 105.67
52wk Range 56.44 - 126.89
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily

Performance

YTD
+13.57%
+13.57%
1 Month
+16.04%
+16.04%
3 Month
+10.34%
+10.34%
6 Month
-1.08%
-1.08%
1 Year
+65.65%
+65.65%

More News

Read More
3 Growth Stocks to Stash
Via StockStory
Exposures COVID-19
Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
Via Benzinga
Lantheus' Pylarify Hit $1B in 2024 Sales
Via The Motley Fool
Earnings Scheduled For February 26, 2025
Via Benzinga
Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals
Via The Motley Fool
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Lantheus (LNTH) Shares Skyrocket, What You Need To Know
Via StockStory
Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars
Via StockStory
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
Via StockStory
NASDAQ:LNTH is not too expensive for the growth it is showing.
Via Chartmill
Lantheus to Present at Upcoming Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
Via Chartmill
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
Via Chartmill
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying.
Via Chartmill
Why Lantheus Holdings Stock Got Thrashed on Tuesday
Via The Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
Via Benzinga
Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
From Lantheus Holdings, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.